Biocon Biologics, Sandoz sign pact to distribute adalimumab

Adalimumab BS for subcutaneous injection is a biosimilar of Humira, offering therapeutic solutions for immune-related diseases such as rheumatoid arthritis, psoriasis vulgaris, ankylosing spondylitis, Crohn's disease and ulcerative colitis

Related Keywords

Japan , Japanese , Biocon Biologics , Biocon Ltd , Fujifilm Kyowa Kirin Biologics Co Ltd , Biocon Biologics Ltd , Biologics Ltd , Adalimumab Biosimilar Market Size , Biocon Biologic , Biocon , Biosimilar , Sandoz , Humira ,